Innate Pharma shares owned by UBS Group
Historical chart of UBS Group investment in Innate Pharma
Tip: Access up to 7 years of quarterly data
All positions including Innate Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Innate Pharma by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.3k | 4.8k | 1.93 |
| 2025-06-30 | $11k | 6.0k | 1.81 |
| 2025-03-31 | $16k | 9.0k | 1.78 |
| 2024-12-31 | $6.5k | 3.5k | 1.84 |
| 2024-09-30 | $19k | 8.4k | 2.29 |
| 2024-06-30 | $575 | 297 | 1.94 |
| 2024-03-31 | $604 | 210 | 2.88 |
| 2023-12-31 | $409 | 146 | 2.80 |
| 2023-09-30 | $369 | 146 | 2.53 |
| 2023-06-30 | $448 | 146 | 3.08 |
| 2023-03-31 | $3.6k | 1.3k | 2.85 |
| 2022-12-31 | $545 | 146 | 3.73 |
| 2022-09-30 | $9.0k | 4.5k | 2.00 |
| 2022-06-30 | $8.0k | 3.0k | 2.71 |